I do wonder if their COViD trial will be held up by product supply issues. They have never had to supply so many cells in such a short time frame. And secondly, if the trial results are brilliant, and the US is happy to fork out 50k + per patient for the treatment, where are all the cells coming from? They couldn’t even keep up with the small demand in japan for GVHD. I would post the questions over their but I would be unlikely to receive a Substantiated reply.....
at least CYP could provide the cells, we just lack the salesman that MSB have
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-177
-
- There are more pages in this discussion • 319 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 19.5¢ | $18.97K | 94.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4999 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |